Enterohemorrhagic Escherichia coli Infections and the Hemolytic-Uremic Syndrome

Medical Clinics of North America

Volumn 97, Issue 4, 2013, Pages 681-695

  Page, Andrea V ^a   Liles, W Conrad ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Eculizumab; Enterohemorrhagic Escherichia coli; Escherichia coli O104:H4; Escherichia coli O157:H7; Hemolytic uremic syndrome; Shiga toxin

Indexed keywords

ANTIHYPERTENSIVE AGENT; AZITHROMYCIN; ECULIZUMAB; SHIGA TOXIN;

ABDOMINAL PAIN; ACUTE KIDNEY FAILURE; ANAMNESIS; ANTIBIOTIC THERAPY; BACTERIAL TRANSMISSION; CLINICAL FEATURE; DIAGNOSTIC TEST; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DISEASE TRANSMISSION; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; ESCHERICHIA COLI INFECTION; FECES ANALYSIS; FEVER; FLUID THERAPY; FOOD FREEZING; FOOD HANDLING; HAND WASHING; HEMOLYTIC ANEMIA; HEMOLYTIC UREMIC SYNDROME; HUMAN; PATHOGENESIS; PRIMARY PREVENTION; PRIORITY JOURNAL; PROGNOSIS; PUBLIC HEALTH; RENAL REPLACEMENT THERAPY; REVIEW; SEROTYPE; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ENTEROHEMORRHAGIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; EUROPE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; PRIMARY PREVENTION; PROGNOSIS; SECONDARY PREVENTION; UNITED STATES;

EID: 84879706641     PISSN: 00257125     EISSN: 15579859     Source Type: Journal    
DOI: 10.1016/j.mcna.2013.04.001     Document Type: Review

References (83)

1. CDC Foodborne Diseases Active Surveillance Network (FoodNet): FoodNet surveillance report for 2011 (final report) 2012, U.S. Department of Health and Human Services, CDC, Atlanta (GA).
2. Scallan E., Hoekstra R.M., Angulo F.J., et al. Foodborne illness acquired in the United States-major pathogens. Emerg Infect Dis 2011, 17:7-15.
3. Kielstein J.T. The German 2011 epidemic of Shiga toxin-producing E. coli-the nephrological view. Nephrol Dial transplant 2011, 29:2723-2726.
4. Cooley M., Carychao D., Crawford-Miksza L. Incidence and tracking of Escherichia coli O157:H7 in a major produce production region in California. PLoS One 2007, 2:e1159.
5. Stanford K., Croy D., Bach S.J., et al. Ecology of Escherichia coli O157:H7 in commercial dairies in Southern Alberta. JDairy Sci 2005, 88:4441-4451.
6. Tuttle J., Gomez T., Doyle M.P., et al. Lessons from a large outbreak of Escherichiacoli O157:H7 infections: insights into the infectious dose and method of widespread contamination of hamburger patties. Epidemiol Infect 1999, 122:185-192.
7. Tilden J., Young W., McNamara A.M., et al. Anew route of transmission for Escherichia coli: infection from dry fermented salami. Am J Public Health 1996, 86:1142-1145.
8. Snedeker K.G., Shaw D.J., Locking M.R., et al. Primary and secondary cases in Escherichia coli O157 outbreaks: a statistical analysis. BMC Infect Dis 2009, 9:144.
9. Bradley K.K., Williams J.M., Burnsed L.J., et al. Epidemiology of a large restaurant-associated outbreak of Shiga toxin-producing Escherichia coli O111:NM. EpidemiolInfect 2012, 140:1644-1654.
10. Brown J.A., Hite D.S., Gillim-Ross L.A., et al. Outbreak of shiga toxin-producing Escherichiacoli serotype O26: H11 infection at a child care center in Colorado. Pediatr Infect Dis J 2012, 31:379-383.
11. Pennington H. Escherichia coli O157. Lancet 2010, 376:1428-1435.
12. House B., Kus J.V., Prayitno N., et al. Acid-stress-induced changes in enterohaemorrhagic Escherichia coli O157: H7 virulence. Microbiology 2009, 155:2907-2918.
13. Bielaszewska M., Mellmann A., Zhang W., et al. Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiologic study. Lancet Infect Dis 2011, 11:671-676.
14. Rohde H., Quin J., Cui Y., et al. Open-source genomic analysis of Shiga-toxin-producing E. coli O104:H4. NEngl J Med 2011, 365:718-724.
15. Rasko D.A., Webster D.R., Sahl J.W., et al. Origins of the E. coli strain causing an outbreak of hemolytic-uremic syndrome in Germany. NEngl J Med 2011, 365:709-717.
16. Brigotti M., Tazzari P.L., Ravanelli E., et al. Endothelial damage induced by Shiga toxins delivered by neutrophils during transmigration. JLeuk Biol 2010, 88:201-210.
17. Obrig T.G., Louise C.B., Lingwood C.A., et al. Endothelial heterogeneity in Shiga toxin receptors and responses. JBiol Chem 1993, 268:15484-15488.
18. Richardson S.E., Rotman T.A., Jay V., et al. Experimental verocytotoxemia in rabbits. Infect Immun 1992, 60:4154-4167.
19. Obata F., Tohyama K., Bonev A.D., et al. Shiga toxin 2 affects the central nervous system through receptor globotriaosylceramide localized to neurons. JInfect Dis 2008, 198:1398-1406.
20. Bitzan M.M., Wang Y., Lin J., et al. Verotoxin and ricin have novel effects on preproendothelin-1 expression but fail to modify nitric oxide Synthase (ecNOS) expression and NO production in vascular endothelium. JClin Invest 1998, 101:372-382.
21. Richardson S.E., Karmali M.A., Becker L.E., et al. The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections. Hum Pathol 1988, 19:1102-1108.
22. Morigi M., Micheletti G., Figliuzzi M., et al. Verotoxin-1 promotes leukocyte adhesion to cultured endothelial cells under physiologic flow conditions. Blood 1995, 86:4553-4558.
23. Morigi M., Galbusera M., Binda E., et al. Verotoxin-1-induced up-regulation of adhesive molecules renders microvascular endothelial cells thrombogenic at high shear stress. Blood 2001, 98:1828-1835.
24. Nolasco L.H., Turner N.A., Bernardo A., et al. Hemolytic uremic syndrome-associated Shiga toxins promote endothelial-cell secretion and impair ADAMTS13 cleavage of unusually large von Willebrand factor multimers. Blood 2005, 106:4199-4209.
25. Bell B.P., Goldoft M., Griffin P.M., et al. Amultistate outbreak of Escherichia coli O157:H7-associated bloody diarrhea and hemolytic uremic syndrome from hamburgers. The Washington experience. JAMA 1994, 272:1349-1353.
26. Tarr P.I., Gordon C.A., Chandler W.L. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 2005, 365:1073-1086.
27. Buteau C., Proulx F., Chaibou M., et al. Leukocytosis in children with Escherichia coli O157:H7 enteritis developing the hemolytic-uremic syndrome. Pediatr Infect Dis J 2000, 19:642-647.
28. Piercefield E.W., Bradley K.K., Coffman R.L., et al. Hemolytic uremic syndrome after an Escherichia coli O111 outbreak. Arch Intern Med 2010, 170:1656-1663.
29. Lopez E.L., Contrini M.M., Glatstein E., et al. An epidemiologic surveillance of Shiga-like toxin-producing Escherichia coli infection in Argentinean children: risk factor and serum Shiga-like toxin 2 values. Pediatr Infect Dis J 2012, 31:20-24.
30. Gould L.H., Bopp C., Strockbine N., et al. Recommendations for diagnosis of shiga toxin-producing Escherichia coli infections by clinical laboratories. MMWR Recomm Rep 2009, 58:1-14.
31. Chandler W.L., Jelacic S., Boster D.R., et al. Prothrombotic coagulation abnormalities preceding the haemolytic-uremic syndrome. NEngl J Med 2002, 346:23-32.
32. Petruzziello-Pellegrini T.N., Yuen D.A., Page A.V., et al. The CXCR4/CXCR7/SDF-1 pathway contributes to the pathogenesis of Shiga toxin-associated hemolytic uremic syndrome in humans and mice. JClin Invest 2012, 122:759-776.
33. Page AV, Tarr PI, Watkins SL, etal. Dysregulation of angiopoietin-1 and -2 in Escherichiacoli O157:H7 infection and the hemolytic-uremic syndrome. J Infect Dis, in press.
34. Ake J.A., Jelacic S., Ciol M.A., et al. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion. Pediatrics 2005, 115:e673-e680.
35. Bell B.P., Griffin P.M., Lozano P., et al. Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections. Pediatrics 1997, 100:E12.
36. Wong C.S., Jelacic S., Habeeb R.L., et al. The risk of the hemolytic-uremic syndromeafter antibiotic treatment of Escherichia coli O157:H7 infections. NEnglJ Med 2000, 342:1930-1936.
37. Wong C.S., Mooney J.C., Brandt J.R., et al. Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis. Clin Infect Dis 2012, 55:33-41.
38. Smith K.E., Wilker P.R., Reiter P.L., et al. Antibiotic treatment of Escherichia coli O157 infection and the risk of hemolytic uremic syndrome, Minnesota. Pediatr Infect Dis J 2012, 31:37-41.
39. Safdar N., Said A., Gangnon R.E., et al. Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta-analysis. JAMA 2002, 288:996-1001.
40. Kimmitt P.T., Harwood C.R., Barer M.R. Toxin gene expression by Shiga toxin-producing Escherichia coli: the role of antibiotics and the bacterial SOS response. Emerg Infect Dis 2000, 6:458-465.
41. Bielaszewska M., Idelevich E.A., Zhang W., et al. Effects of antibiotics on Shiga toxin 2 production and bacteriophage induction by epidemic Escherichia coli O104:H4 strain. Antimicrob Agents Chemother 2012, 56:3277-3282.
42. Corogeanu D., Willmes R., Wolke M., et al. Therapeutic concentrations of antibiotics inhibit Shiga toxin release from enterohemorrhagic E. coli O104:H4 from the 2011 German outbreak. BMC Microbiol 2012, 12:160.
43. Nitschke M., Sayk F., Hartel C., et al. Association between azithromycin therapy and duration of bacterial shedding among patients with Shiga toxin-producing enteroaggregative Escherichia coli O104:H4. JAMA 2012, 307:1046-1052.
44. Bitzan M., Shaefer F., Reymond D. Treatment of typical (enteropathic) hemolytic uremic syndrome. Semin Thromb Hemost 2010, 36:594-610.
45. Tarr P.I., Sadler J.E., Chandler W.L., et al. Should all adult patients with diarrhoea-associated HUS receive plasma exchange?. Lancet 2012, 379:516.
46. Kielstein J.T., Beutel G., Fleig S., et al. Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome: an analysis of the German STEC-HUS registry. Nephrol Dial Transplant 2012, 27:3807-3815.
47. Loos S., Ahlenstiel T., Kranz B., et al. An outbreak of Shiga toxin-producing Escherichiacoli O104:H4 hemolytic uremic syndrome in Germany: presentation and short-term outcome in children. Clin Infect Dis 2012, 55:753-759.
48. Tarr P.I., Karpman D. Escherichia coli O104:H4 and hemolytic uremic syndrome: the analysis begins. Clin Infect Dis 2012, 55:760-763.
49. Stahl A.L., Sartz L., Karpman D. Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome. Blood 2011, 117:5503-5513.
50. Lapeyraque A.L., Malina M., Fremeaux-Bacchi V., et al. Eculizumab in severe Shiga-toxin-associated HUS. NEngl J Med 2011, 364:2561-2563.
51. Menne J., Nitschke M., Stingele R., et al. Validation of treatment strategies for enterohaemorrhagicEscherichia coli O104:H4 induced haemolytic uraemic syndrome:case-control study. BMJ 2012, 345:e4565.
52. Clark W.F., Sontrop J.M., Macnab J.J., et al. Long term risk for hypertension, renal impairment, and cardiovascular disease after gastroenteritis from drinking water contaminated with Escherichia coli O157:H7: a prospective cohort study. BMJ 2010, 341:c6020.
53. Garg A.X., Suri R.S., Barrowman N., et al. Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome. JAMA 2003, 290:1360-1370.
54. Rosales A., Hofer J., Zimmerhackl L.B., et al. Need for long-term follow-up in enterohemorrhagic Escherichia coli-associated hemolytic uremic syndrome due to late-emerging sequelae. Clin Infect Dis 2012, 54:1413-1421.
55. Gould H.L., Demma L., Jones T.F., et al. Hemolytic uremic syndrome and death in persons with Escherichia coli O157:H7 infection, Foodborne Diseases Active Surveillance Network Sites, 2000-2006. Clin Infect Dis 2009, 49:1480-1485.
56. Centers for Disease Control (CDC). E. coli infection. Available at: Accessed April 4, 2013. http://www.cdc.gov/Features/EcoliInfection/.
57. Werber D., Mason B.W., Evans M.R., et al. Preventing household transmission of Shiga toxin-producing Escherichia coli O157 infection: promptly separating siblings might be the key. Clin Infect Dis 2008, 46:1189-1196.
58. Ahn C.K., Klein E., Tarr P.I. Isolation of patients acutely infected with Escherichia coli O157:H7: low-tech, highly effective prevention of hemolytic uremic syndrome. Clin Infect Dis 2008, 46:1197-1199.
59. Abu Sin M., Takla A., Flieger A., et al. Carrier prevalence, secondary household transmission, and long-term shedding in 2 districts during the Escherichia coli O104:H4 outbreak in Germany, 2011. JInfect Dis 2013, 207:432-438.
60. Vonberg R.P., Hohle M., Aepfelbacker M., et al. Duration of fecal shedding of Shiga toxin-producing Escherichia coli O104:H4 in patients infected during the 2011 outbreak in Germany: a multicenter study. Clin Infect Dis 2013, 56:1132-1140.
61. Centers for Disease Control (CDC). Multistate outbreak of shiga toxin-producing Escherichia coli O121 infections linked to farm rich brand frozen food products. Available at: Accessed April 4, 2013. http://www.cdc.gov/ecoli/2013/O121-03-13/index.html.
62. Centers for Disease Control (CDC). Multistate outbreak of Shiga toxin-producing Escherichia coli O26 infections linked to raw clover sprouts at Jimmy John's restaurants. 2012. Available at: Accessed April 4, 2013. http://www.cdc.gov/ecoli/2012/o26-02-12/index.html.
63. Centers for Disease Control (CDC). Multistate outbreak of Shiga toxin-producing Escherichia coli O157:H7 infections linked to organic spinach and spring mix blend. 2012. Available at: Accessed April 4, 2013. http://www.cdc.gov/ecoli/2012/O157H7-11-12/index.html.
64. Wendel A.M., Johnson D.H., Sharapov U., et al. Multistate outbreak of Escherichia coli O157:H7 infection associated with consumption of packaged spinach, August-September, 2006: the Wisconsin Investigation. Clin Infect Dis 2009, 48:1079-1086.
65. Soborg B., Lassen S.G., Muller L., et al. Averocytotoxin-producing E. coli outbreak with a surprisingly high risk of haemolytic uraemic syndrome, Denmark, September-October, 2012. Euro Surveill 2013, 18. pii:20350.
66. Ethelberg S., Smith B., Torpdahl M., et al. Outbreak of non-O157 Shiga toxin-producing Escherichia coli infection from consumption of beef sausage. Clin Infect Dis 2009, 48:e78-e81.
67. Slayton R.B., Turabelidze G., Bennett S.D., et al. Outbreak of Shiga toxin-producing Escherichia coli (STEC) O157:H7 associated with romaine lettuce consumption, 2011. PLoS One 2013, 8:e55300.
68. Folster J.P., Pecic G., Taylor E., et al. Characterization of isolates from an outbreak of multidrug-resistant, Shiga toxin-producing Escherichia coli O145 in the United States. Antimicrob Agents Chemother 2011, 55:5955-5956.
69. Karch H., Denamur E., Dobrindt U., et al. The enemy within us: lessons from the 2011 European Escherichia coli O104:H4 outbreak. EMBO Mol Med 2012, 4:841-848.
70. Frank C., Werber D., Cramer J.P., et al. Epidemic profile of Shiga-toxin-producing Escherichiacoli O104:H4 outbreak in Germany. NEngl J Med 2011, 365:1771-1780.
71. Robert Koch Institute Report: final presentation and evaluation of epidemiological findings in the EHEC O104:H4 outbreak, Germany 2011 2011, Robert Koch Institute, Berlin.
72. King L.A., Nogareda F., Weill F.X., et al. Outbreak of Shiga toxin-producing Escherichiacoli O104:H4 associated with organic fenugreek sprouts, France, June, 2011. Clin Infect Dis 2012, 54:1588-1594.
73. Guh A., Phan Q., Nelson R., et al. Outbreak of Escherichia coli O157 associated with raw milk, Connecticut, 2008. Clin Infect Dis 2010, 51:1411-1417.
74. Neil K.P., Biggerstaff G., MacDonald J.K., et al. Anovel vehicle for transmission of Escherichia coli O157:H7 to humans: multistate outbreak of E. coli O157:H7 infectionsassociated with consumption of ready-to-bake commercial prepackaged cookie dough-United States, 2009. Clin Infect Dis 2012, 54:511-518.
75. Ihekweazu C., Carroll K., Adak B., et al. Large outbreak of verocytotoxin-producing Escherichia coli O157 infection in visitors to a petting farm in South East England, 2009. Epidemiol Infect 2012, 140:1400-1413.
76. Goode B., O'Reilly C., Dunn J., et al. Outbreak of Escherichia coli O157: H7 infections after Petting Zoo visits, North Carolina State Fair, October-November, 2004. Arch Pediatr Adolesc Med 2009, 163:42-48.
77. An outbreak of Escherichia coli O157:H7 associated with a children's water spray park and identified by two rounds of pulsed-field gel electrophoresis testing. Can Commun Dis Rep 2005, 31:133-140. [in English, French].
78. Cody S.H., Glynn M.K., Farrar J.A., et al. An outbreak of Escherichia coli O157:H7 infection from unpasteurized commercial apple juice. Ann Intern Med 1999, 130:202-209.
79. Yoshioka K., Yagi K., Moriguchi N. Clinical features and treatment of children with hemolytic uremic syndrome caused by enterohemorrhagic Escherichia coli O157:H7 infection: experience of an outbreak in Sakai City, 1996. Pediatr Int 1999, 41:223-227.
80. Hadler J.L., Clogher P., Hurd S., et al. Ten-year trends and risk factors for non-O157 Shiga toxin-producing Escherichia coli found through Shiga toxin testing, Connecticut, 2000-2009. Clin Infect Dis 2011, 53:269-276.
81. Klein E.J., Stapp J.R., Clausen C.R., et al. Shiga toxin-producing Escherichia coli in children with diarrhea: a prospective point-of-care study. JPediatr 2002, 141:172-177.
82. Magnus T., Rother J., Simova O., et al. The neurological syndrome in adults during the 2011 northern German E. coli serotype O104:H4 outbreak. Brain 2012, 135:1850-1859.
83. Slutsker L., Ries A.A., Greene K.D., et al. Escherichia coli O157:H7 diarrhea in the United States: clinical and epidemiologic features. Ann Intern Med 1997, 126:505-513.